| Muhammad A Habib, MD | |
|
2285 Sequoia Dr, Aurora, IL 60506-6209 | |
| (630) 859-6910 | |
| Not Available |
| Full Name | Muhammad A Habib |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 22 Years |
| Location | 2285 Sequoia Dr, Aurora, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144362773 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 24556 (Oklahoma) | Secondary |
| 207Q00000X | Family Medicine | 036-139423 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Osf Saint Anthony Medical Center | Rockford, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Anthony Medical Center | 5496654006 | 42 |
| Advocate Health And Hospitals Corporation | 7810800935 | 2422 |
News Archive
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Health care, unemployment, immigration, and education top a lengthy and varied list of the American public's policy priorities for 2017, according to a new national survey conducted by The Associated Press-NORC Center for Public Affairs Research.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
› Verified 3 days ago
| Entity Name | Saint Anthony Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942248802 PECOS PAC ID: 5496654006 Enrollment ID: O20040102000555 |
News Archive
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Health care, unemployment, immigration, and education top a lengthy and varied list of the American public's policy priorities for 2017, according to a new national survey conducted by The Associated Press-NORC Center for Public Affairs Research.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
› Verified 3 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Health care, unemployment, immigration, and education top a lengthy and varied list of the American public's policy priorities for 2017, according to a new national survey conducted by The Associated Press-NORC Center for Public Affairs Research.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
› Verified 3 days ago
| Entity Name | Advocate Health And Hospitals Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003542184 PECOS PAC ID: 7810800935 Enrollment ID: O20220930002728 |
News Archive
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Health care, unemployment, immigration, and education top a lengthy and varied list of the American public's policy priorities for 2017, according to a new national survey conducted by The Associated Press-NORC Center for Public Affairs Research.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muhammad A Habib, MD 28594 Network Pl, Chicago, IL 60673-1285 Ph: () - | Muhammad A Habib, MD 2285 Sequoia Dr, Aurora, IL 60506-6209 Ph: (630) 859-6910 |
News Archive
The benefits of routine lung cancer screenings have been hotly debated in the medical community. After reviewing a national trial published in 2011, the US Preventive Services Task Force introduced a recommendation for systematic low-dose CT lung cancer screenings for people at high risk.
Health care, unemployment, immigration, and education top a lengthy and varied list of the American public's policy priorities for 2017, according to a new national survey conducted by The Associated Press-NORC Center for Public Affairs Research.
The U.S. Food and Drug Administration today approved Prevnar 13, a pneumococcal 13-valent conjugate vaccine for infants and young children ages 6 weeks through 5 years. Prevnar 13 will be the successor to Prevnar, the pneumococcal 7-valent conjugate vaccine licensed by the FDA in 2000 to prevent invasive pneumococcal disease (IPD) and otitis media. The new vaccine extends the protection to six additional types of the disease causing bacteria.
Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, announced the results of an independent human clinical study that demonstrated intake of its proprietary Ambrotose AO capsules raised antioxidant protection in serum oxygen radical absorbance capacity in healthy adults, further validating a previous human study.
› Verified 3 days ago
Joseph Robert Rojas, Family Medicine Medicare: Medicare Enrolled Practice Location: 2020 Ogden Ave, Aurora, IL 60504 Phone: 630-978-4850 Fax: 630-978-6865 | |
Jurate Kunickaite, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6859 | |
Daniel E Hrad, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4205 Westbrook Dr, Aurora, IL 60504 Phone: 630-527-1818 Fax: 630-527-1244 | |
Aruna Galla-pagadala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 | |
Kuchipudi Veerraju, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 475 N Farnsworth Ave, Aurora Medical Clinic, Aurora, IL 60505 Phone: 630-898-0022 Fax: 630-898-2933 | |
Dr. Robert D. Paras, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2111 Ogden Ave, Aurora, IL 60504 Phone: 630-978-3800 Fax: 630-862-3085 | |
Dr. Mona Habiba Waheed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2285 Sequoia Dr, Aurora, IL 60506 Phone: 630-859-6700 |